African American Patients With Hypertensive Chronic Kidney Disease Receive No Benefit on Kidney Disease Progression from the Currently Recommended Blood Pressure Goal of <130/80mmHg Unless There Is Significant Proteinuria at Baseline: Long-Term Follow-Up of the AASK Study

Journal of Clinical Hypertension

Volumn 13, Issue 3, 2011, Pages 214-216

  Bloch, Michael J ^a,b   Basile, Jan ^c,d  

^a University of Nevada School of Medicine   (United States)

^b Saint Mary's   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CLONIDINE; DOXAZOSIN; FUROSEMIDE; HYDRALAZINE; METOPROLOL SUCCINATE; MINOXIDIL; RAMIPRIL;

AFRICAN AMERICAN; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE;

EID: 79952136186     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00409.x     Document Type: Note

References (0)